FDA Clears CLEW Medical’s AI-Based ICU Solution
The FDA has cleared CLEWICU, CLEW Medical’s AI-based solution, for predicting hemodynamic instability in an ICU setting.
The FDA has cleared CLEWICU, CLEW Medical’s AI-based solution, for predicting hemodynamic instability in an ICU setting.
The FDA has cleared CLEWICU, CLEW Medical’s AI-based solution, for predicting hemodynamic instability in an ICU setting.